Neurotoxicity Syndromes Clinical Trials

Find Neurotoxicity Syndromes Clinical Trials Near You

Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The proposed multimodal telerehabilitation model allows a rehabilitation therapy team to set up individualized rehabilitation plans using a web-based care management portal and monitor patient progress online. Patients at home follow a safe and effective personalized exercise and nutrition plan guided by interactive touch-screen technology combined with behavioral counseling, social support, and interactive education and empowerment. The design of the telerehabilitation system is based on the cloud-based Internet-of-Things architecture allowing real-time monitoring of cardiovascular parameters and exercise performance. The patient's level of exertion during exercise is automatically identified by a validated AI-driven algorithm supporting exercise safety and efficacy. The ultimate goal of this pilot feasibility project is to establish the extent of the impact of the proposed patient-centered cancer telerehabilitation model on disease-specific quality of life, and functional and symptom outcomes and to obtain sufficient evidence for a definitive randomized clinical trial evaluating this approach in a multi-center study.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Healthy Volunteers: f
View:

• age \>21

• confirmed diagnosis of lymphoma or myeloma

• commercial FDA-approved CAR-T delivery planned for ≥4 weeks following enrollment

• Eastern Cooperative Oncology Group (ECOG) performance status 0-2.

• Access to a working telephone line in their home or a cell phone.

Locations
United States
Utah
Huntsman Cancer Institute at University of Utah
RECRUITING
Salt Lake City
Contact Information
Primary
Aileen Gabriel
aileen.gabriel@utah.edu
801-585-3229
Time Frame
Start Date: 2025-09-01
Estimated Completion Date: 2029-01
Participants
Target number of participants: 40
Treatments
Experimental: Multimodal Cancer Telerehabilitation
Each enrolled patient will undergo a four-week multimodal prehabilitation before the commencement of the CAR-T therapy. During CAR-T therapy, the patients will use an interactive app supporting cancer self-care education and early mobilization while undergoing chemotherapy, infusion, in-hospital toxicity monitoring, and recovery (the duration depends on the specific CAR-T treatment regimen). After completion of the CAR-T procedures and hospital discharge, the patients will undergo a 12-week home-based multimodal telerehabilitation.~Individualized rehabilitation plans using a web-based care management portal. Patients at home follow a safe and effective personalized exercise and nutrition plan guided by interactive touch-screen technology combined with behavioral counseling, social support, and interactive education and empowerment.
Related Therapeutic Areas
Sponsors
Leads: University of Utah
Collaborators: United States Department of Defense

This content was sourced from clinicaltrials.gov